rawfin.tv
FDA Approves LivaNova's aura6000 Neurostimulator for Sleep Apnea
RegulationstocksAI Generated

FDA Approves LivaNova's aura6000 Neurostimulator for Sleep Apnea

By rawfin.tv Markets Desk||Updated |1 min read|AI-assisted · Methodology

The U.S. Food and Drug Administration has granted approval for LivaNova's aura6000 System, a neurostimulator designed to treat adults suffering from moderate to severe obstructive sleep apnea. This regulatory clearance is expected to boost the company's medical device offerings.

Medical DevicesHealthcareFDA ApprovalLivaNovaSleep Apnea

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks